Follow
Kelly Bree
Kelly Bree
Assistant Professor of Urology at MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Residents-as
KK Bree, SA Whicker, HB Fromme, S Paik, L Greenberg
teachers publications: what can programs learn from the literature when …, 2014
582014
Residents-as-teachers publications: what can programs learn from the literature when starting a new or refining an established curriculum?
KK Bree, SA Whicker, HB Fromme, S Paik, L Greenberg
Journal of Graduate Medical Education 6 (2), 237-248, 2014
412014
Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non–muscle-invasive bladder cancer treated …
N Lobo, PJ Hensley, KK Bree, GM Nogueras-Gonzalez, N Navai, ...
European Urology Oncology 5 (1), 84-91, 2022
302022
Management, surveillance patterns, and costs associated with low-grade papillary stage ta non–muscle-invasive bladder cancer among older adults, 2004-2013
KK Bree, Y Shan, PJ Hensley, N Lobo, C Hu, DS Tyler, K Chamie, ...
JAMA network open 5 (3), e223050-e223050, 2022
282022
Contemporary rates of gynecologic organ involvement in females with muscle invasive bladder cancer: a retrospective review of women undergoing radical cystectomy following …
KK Bree, PJ Hensley, ME Westerman, A Kokorovic, ...
The Journal of urology 206 (3), 577-585, 2021
202021
Current therapy and emerging intravesical agents to treat non–muscle invasive bladder cancer
KK Bree, NA Brooks, AM Kamat
Hematology/Oncology Clinics 35 (3), 513-529, 2021
192021
Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis
F Ghali, AA Elbakry, ZA Hamilton, K Yim, R Nasseri, S Patel, A Eldefrawy, ...
World journal of urology 38, 1113-1122, 2020
152020
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre
N Lobo, KK Bree, PJ Hensley, GM Nogueras‐Gonzalez, P Abraham, ...
BJU international 130 (3), 323-330, 2022
142022
All high-grade Ta tumors should be classified as high risk: bacillus Calmette-Guérin response in high-grade Ta tumors
KK Bree, PJ Hensley, N Lobo, NA Brooks, GM Nogueras-Gonzalez, ...
Journal of Urology 208 (2), 284-291, 2022
112022
Sequential intravesical gemcitabine and docetaxel is an alternative to bacillus Calmette-Guérin for the treatment of intermediate-risk non–muscle-invasive bladder cancer
WS Tan, IM McElree, F Davaro, RL Steinberg, K Bree, N Navai, ...
European urology oncology 6 (5), 531-534, 2023
102023
Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study
ME Westerman, KK Bree, P Msaouel, JB Kukreja, C Mantaring, I Rukundo, ...
The Journal of urology 208 (4), 886-895, 2022
92022
Progression of disease after bacillus Calmette-Guérin therapy: refining patient selection for neoadjuvant chemotherapy before radical cystectomy
PJ Hensley, KK Bree, MT Campbell, O Alhalabi, A Kokorovic, T Miest, ...
The Journal of Urology 206 (5), 1258-1267, 2021
92021
What women want: radical cystectomy and perioperative sexual function educational needs
ME Westerman, KK Bree, A Kokorovic, J Frank, XS Wang, AM Kamat, ...
Urology 157, 181-187, 2021
92021
Germline predisposition to prostate cancer in diverse populations
KK Bree, PJ Hensley, CA Pettaway
Urologic Clinics 48 (3), 411-423, 2021
92021
Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response
PJ Hensley, KK Bree, N Brooks, J Matulay, R Li, GM Nogueras Gonzalez, ...
BJU international 128 (5), 634-641, 2021
72021
Oncological outcomes for patients with European Association of Urology very high-risk non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin or early radical …
R Contieri, PJ Hensley, WS Tan, V Grajales, K Bree, ...
European Urology Oncology 6 (6), 590-596, 2023
52023
Bladder-sparing treatment in patients with bacillus Calmette-Guerin–unresponsive non–muscle-invasive bladder cancer: an analysis of long-term survival outcomes
WS Tan, V Grajales, R Contieri, P Hensley, K Bree, P Msaouel, CC Guo, ...
European Urology Open Science 53, 16-22, 2023
52023
Germline mutations in African American men with prostate cancer: incidence, implications and diagnostic disparities
KK Bree, PJ Hensley, CA Pettaway
Urology 163, 148-155, 2022
52022
Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center
KK Bree, PJ Hensley, N Brooks, J Matulay, GM Nogueras-Gonzalez, ...
World journal of urology 39 (11), 4143-4149, 2021
52021
Impact of age> 70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette–Guérin
R Contieri, V Grajales, WS Tan, A Martini, A Sood, P Hensley, K Bree, ...
BJU international 133 (1), 63-70, 2024
42024
The system can't perform the operation now. Try again later.
Articles 1–20